Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NDFOS is a South Korea-listed materials company that primarily develops and manufactures adhesive tapes and functional films for electronics, automotive, and architectural applications. Its core products include double-sided tapes for touch screen panels and specialty films such as solar control, paint protection, and windshield protection films. The company has also diversified into bioengineering and early-stage oncology R&D through investments and affiliated development efforts including NeoTx and CureBio-related programs. On its website, NDFOS describes a preclinical immuno-oncology platform called STR aimed at selective T-cell activation against solid tumors. Despite this bioengineering activity, NDFOS is best characterized as an industrial materials company rather than a pure-play biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NDFOS.